Ranitidine to Reduce Stomach Acid (Zantac)
Comprehensive guide to ranitidine (Zantac): uses, dosage, side effects, and precautions for treating stomach acid conditions effectively.
Ranitidine, commonly known by the brand name Zantac (now discontinued in some forms), is a medication used to decrease stomach acid production. It belongs to a class of drugs called histamine H2-receptor antagonists, or H2 blockers, which competitively inhibit histamine at H2-receptors on gastric cells to reduce acid secretion.
| Type of Medicine | Details |
|---|---|
| Used for | Treatment of conditions caused by excess stomach acid, such as ulcers and GERD |
| Also called | Zantac® (discontinued) |
| Available as | Tablets, oral liquid, injection |
About Ranitidine
Ranitidine effectively reduces acid produced by stomach lining cells, helping to heal and prevent ulcers, relieve heartburn, and manage gastroesophageal reflux disease (GERD). Unlike antacids, which neutralize existing acid, H2 blockers like ranitidine prevent acid production, providing longer-lasting relief.
Chemically, ranitidine hydrochloride is N[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N′-methyl-2-nitro-1,1-ethenediamine hydrochloride. It is available in various forms, including 150 mg and 300 mg tablets, oral syrup, and injectable solutions.
Key Uses of Ranitidine
Ranitidine is indicated for several acid-related conditions:
- Short-term treatment of active duodenal ulcers: Most patients heal within 4 weeks.
- Short-term treatment of active benign gastric ulcers: Healing typically occurs within 6 weeks.
- Maintenance therapy: For duodenal and gastric ulcers after initial healing to prevent recurrence.
- Treatment of pathological hypersecretory conditions: Such as Zollinger-Ellison syndrome, where it controls acid output and reduces symptoms like diarrhea and pain.
- Gastroesophageal reflux disease (GERD): Relieves heartburn and other symptoms; more effective than placebo in clinical trials.
- Erosive esophagitis: Heals damage to the esophagus caused by acid reflux.
- Heartburn prevention: Associated with acid indigestion and sour stomach.
In Zollinger-Ellison syndrome patients, continuous IV ranitidine infusion controlled acid output to ≤10 mEq/h without complications like bleeding or perforation in studied cases.
How to Take Ranitidine
Follow your doctor’s instructions precisely. Typical oral dosing for adults includes 150 mg twice daily or 300 mg once at bedtime for ulcer treatment. Absorption is not significantly affected by food or antacids, though high-dose antacids may slightly reduce it.
Dosage guidelines:
| Condition | Adult Dosage | Duration |
|---|---|---|
| Duodenal ulcer (active) | 150 mg twice daily or 300 mg at bedtime | 4-8 weeks |
| Gastric ulcer (active) | 150 mg twice daily or 300 mg at bedtime | 6 weeks |
| Maintenance (duodenal ulcer) | 150 mg at bedtime | Up to 48 weeks |
| GERD | 150 mg twice daily | 6-12 weeks |
| Zollinger-Ellison | 150 mg every 6-8 hours (adjust as needed) | Long-term |
For renal impairment (creatinine clearance <50 mL/min), reduce to 150 mg every 24 hours, increasing cautiously if needed. Hemodialysis removes ranitidine, so time doses accordingly.
Swallow tablets whole with water. For effervescent forms, note phenylalanine content for phenylketonurics (2.81 mg per 25 mg ranitidine).
Important Precautions
- Gastric malignancy: Symptom relief does not rule out stomach cancer; seek endoscopy if symptoms persist.
- Renal impairment: Adjust dosage as clearance decreases proportionally.
- Hepatic dysfunction: Use caution; monitor liver enzymes with high IV doses.
- Pregnancy/Breastfeeding: Generally considered safe, but consult a doctor.
- Porphyria: Avoid in patients with acute porphyria history.
- Elderly: Prolonged half-life (3.1 hours); reduce dose if renal function impaired.
Common Side Effects
Ranitidine is well-tolerated, but side effects can occur:
- Gastrointestinal: Constipation, diarrhea, nausea, vomiting, abdominal pain, rare pancreatitis.
- Headache and dizziness: Most frequent.
- Hepatic: Elevated SGPT (especially with high IV doses); rare hepatitis or failure—discontinue if occurs.
- Cardiovascular: Rare arrhythmias (tachycardia, bradycardia).
- Other: Fatigue, rash; hypersensitivity reactions rare.
In trials, IV ranitidine at ≥100 mg four times daily for >5 days raised SGPT in some volunteers—monitor daily from day 5.
Serious Side Effects and Overdose
Seek immediate medical help for severe reactions like jaundice, severe abdominal pain, irregular heartbeat, or confusion. Overdose (up to 18 g oral) causes transient effects like gait abnormalities and hypotension; no specific antidote—supportive care.
Interactions with Other Medicines
Ranitidine may interact with:
- Procainamide: Reduced renal excretion, increasing levels—monitor.
- Antacids: High doses may decrease absorption.
- Propantheline: Delays peak levels.
- Ketoconazole: May reduce absorption.
- Warfarin: Rare potentiation of anticoagulant effect.
Always inform your doctor of all medications.
Alternatives to Ranitidine
Zantac was recalled in some markets due to NDMA concerns, leading to alternatives like famotidine (Pepcid), cimetidine, proton pump inhibitors (PPIs) like omeprazole, or antacids. Consult a healthcare provider for switches.
Frequently Asked Questions (FAQs)
Q: What is ranitidine used for?
A: Ranitidine treats and prevents ulcers, GERD, heartburn, and hypersecretory conditions by reducing stomach acid.
Q: How quickly does ranitidine work?
A: Oral doses reduce acid within 1-3 hours, peaking at 2-3 hours; effects last 8-12 hours.
Q: Can I take ranitidine with food?
A: Yes, food does not significantly impair absorption.
Q: Is ranitidine safe for long-term use?
A: Suitable for maintenance up to 48 weeks in ulcers; monitor for side effects in prolonged use.
Q: What if I miss a dose?
A: Take as soon as remembered unless near next dose; do not double up.
Q: Does ranitidine cause weight gain?
A: Not commonly reported; rare GI effects may indirectly affect appetite.
Pharmacology and Clinical Data
Ranitidine’s half-life is 2-3 hours in healthy adults, extending to 4.8 hours in severe renal impairment. It inhibits 50% of stimulated acid secretion at 36-94 ng/mL serum levels, achieved for 12 hours post-150 mg dose.
In GERD trials, 150 mg twice daily outperformed placebo, reducing antacid use. For Zollinger-Ellison, 42% of intractable cases healed.
Inactive ingredients include microcrystalline cellulose, magnesium stearate; check for allergies.
References
- ZANTAC- ranitidine hydrochloride injection, solution — DailyMed (NIH). 2023. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=95dc4515-7690-4881-ae14-9f8655a68dfe
- Zantac FDA Label — FDA (AccessData). 2009-08-14. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/018703s068,019675s035,020251s019lbl.pdf
- Ranitidine to reduce stomach acid – Zantac — Patient.info. Accessed 2026. https://patient.info/medicine/ranitidine-to-reduce-stomach-acid-zantac
- Zantac Tablets — NPS MedicineWise. Accessed 2026. https://www.nps.org.au/medicine-finder/zantac-tablets
- Ranitidine: Uses, Interactions — DrugBank. Accessed 2026. https://go.drugbank.com/drugs/DB00863
Similar Articles
Read full bio of Sneha Tete
